Insider trade

Director received an award of 323 BSX shares

Traded Mar 2, 2026 · Filed Mar 5, 2026

Boston ScientificBSX

323
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 2, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 5, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-26-003178
Filed / recorded

Mar 5, 2026, 12:35 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BOSTON SCIENTIFIC CORP

Issuer CIK

885725

Ticker

BSX

Reporting person

Christophe Pierre Weber

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 2, 2026

Transaction code

A

Shares / units

323

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

879

Ownership form

Direct

Amendment

No

Footnotes from the filing

Grant of restricted stock in lieu of 100% yearly cash compensation, following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2026 annual meeting of stockholders. Reflects a value of approximately $24,662.50 (representing 100% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.